COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers
Clinical trial NCT04591717 · COMPLETED
Trial details
- NCT number
- NCT04591717
- Sponsor
- ImmunityBio, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-19
- Primary completion
- 2022-04-20
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.